RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 3.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $891,000 | -35.2% | 374,383 | -0.2% | 0.00% | -50.0% |
| Q3 2016 | $1,376,000 | +78.0% | 375,016 | +8.2% | 0.00% | +100.0% |
| Q2 2016 | $773,000 | +17.5% | 346,722 | +9.5% | 0.00% | 0.0% |
| Q1 2016 | $658,000 | -32.2% | 316,511 | -1.1% | 0.00% | 0.0% |
| Q4 2015 | $970,000 | +23.9% | 320,112 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $783,000 | -24.6% | 316,909 | -2.1% | 0.00% | 0.0% |
| Q2 2015 | $1,039,000 | +0.8% | 323,610 | +12.1% | 0.00% | 0.0% |
| Q1 2015 | $1,031,000 | +56.4% | 288,736 | -0.5% | 0.00% | 0.0% |
| Q4 2014 | $659,000 | -5.3% | 290,262 | -19.1% | 0.00% | 0.0% |
| Q3 2014 | $696,000 | -47.0% | 358,627 | -0.8% | 0.00% | -50.0% |
| Q2 2014 | $1,312,000 | +13.8% | 361,558 | +21.7% | 0.00% | 0.0% |
| Q1 2014 | $1,153,000 | +35.6% | 297,076 | -0.4% | 0.00% | +100.0% |
| Q4 2013 | $850,000 | -21.9% | 298,344 | -1.9% | 0.00% | -50.0% |
| Q3 2013 | $1,089,000 | +7.9% | 304,203 | +0.7% | 0.00% | 0.0% |
| Q2 2013 | $1,009,000 | – | 301,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |